Skip to main content

GP Prescribing Intensity in Cheshire and Merseyside

Real NHSBSA prescribing data for NHS Cheshire and Merseyside Integrated Care Board, March 2026 — antibiotic, antidepressant and opioid items per 1,000 patients, plus the Gera Prescribing Intensity Index (GPII).

What are the antibiotic, antidepressant and opioid prescribing rates in Cheshire and Merseyside?

In March 2026, Cheshire and Merseyside had 53.9 antibiotic, 164.8 antidepressant and 39.8 opioid items per 1,000 registered patients, giving a Gera Prescribing Intensity Index of 64/100 (rank 8 of 42), above England average, per NHSBSA EPD data.

Gera Prescribing Intensity Index64 / 100Cheshire and Merseyside ranks 8 of 42 ICBs — above England average across antibiotic, antidepressant and opioid prescribing. GPII 100 = highest intensity (North East and North Cumbria); GPII 0 = lowest (North West London).How this index is calculated
Cheshire and Merseyside — prescribing rates vs England average, March 2026 (NHSBSA EPD, OGL v3.0)
CategoryCheshire and Merseyside rateEngland ratevs NationalTotal items
Antibiotics (BNF ch05)53.9 /1k48.8 /1k+5.0150,984
Antidepressants (§04.03)164.8 /1k128.5 /1k+36.3461,712
Opioid analgesics (§04.07.02)39.8 /1k29.8 /1k+10.0111,516
Registered patients2,802,10163,766,671
GPII (0–100)64 / 100≈42.6 (England equiv.)Rank 8 of 42

Compare prescribing rates across ICBs

Pick any Integrated Care Board to see its antibiotic, antidepressant and opioid rates vs the England average, with GPII rank.

Cheshire and Merseyside

NHS Cheshire and Merseyside Integrated Care Board

64
GPII / 100

Cheshire and Merseyside is above England average across the three key prescribing chapters — ranked 8 of 42 ICBs by combined prescribing intensity (March 2026).

CategoryThis ICB /1kEngland /1kvs National
Antibiotics53.948.8+5.0
Antidepressants164.8128.5+36.3
Opioid analgesics39.829.8+10.0
150,984
antibiotic items
461,712
antidepressant items
111,516
opioid items

Registered patients: 2,802,101 (QOF HYP listSize 2024/25). Data: NHSBSA EPD March 2026, OGL v3.0. Full Cheshire and Merseyside page →

How Cheshire and Merseyside compares to other ICBs

GPII rank 8 of 42. ICBs near the top of the intensity scale:

View all 42 ICBs →

GP prescribing in Cheshire and Merseyside: frequently asked questions

What is the antibiotic prescribing rate in Cheshire and Merseyside?
In March 2026, Cheshire and Merseyside had 53.9 antibiotic items per 1,000 registered patients (BNF chapter 05: Infections), from 150,984 total antibiotic items across 2,802,101 registered patients. The England average is 48.8 per 1,000; Cheshire and Merseyside is +5.0 vs national.
How does Cheshire and Merseyside's antidepressant prescribing compare to England?
Cheshire and Merseyside had 164.8 antidepressant items per 1,000 patients (BNF §04.03) in March 2026, compared to the England average of 128.5 per 1,000 — +36.3 vs national. Total antidepressant items: 461,712.
What is the opioid prescribing rate in Cheshire and Merseyside?
Cheshire and Merseyside prescribed 39.8 opioid analgesic items per 1,000 patients (BNF §04.07.02) in March 2026. The England average is 29.8 per 1,000; Cheshire and Merseyside is +10.0 vs national. Total opioid items: 111,516.
What is Cheshire and Merseyside's GPII and what does it mean?
Cheshire and Merseyside scores 64/100 on the Gera Prescribing Intensity Index — above England average. The GPII combines antibiotic, antidepressant and opioid rates (each normalised against the England average) into a single 0–100 score. GPII 100 = NHS North East and North Cumbria (highest intensity); GPII 0 = NHS North West London (lowest). Cheshire and Merseyside ranks 8 of 42. See the methodology for the full formula.

Concerned about your prescriptions or health trends in Cheshire and Merseyside?

GeraClinic connects you with UK-registered GPs online — for prescription reviews, mental health support and pain management. Often available in under 30 minutes, including evenings and weekends.

Contains public sector information published by NHS Business Services Authority (NHSBSA) and licensed under the Open Government Licence v3.0. Source: NHS Business Services Authority — English Prescribing Dataset (EPD) with SNOMED Code, March 2026 (March 2026, published May 2026).